Citation Impact
Citing Papers
Drug development in Alzheimer’s disease: the path to 2025
2016
Adverse Health Effects of Marijuana Use
2014 Standout
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
2013
Polypharmacology of dopamine receptor ligands
2016
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
2015
Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism
2013
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
A perspective on multi‐target drug discovery and design for complex diseases
2018
Works of Naoki Amada being referenced
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
2011
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
2014
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success
2015
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
2013